NEIL WILKEY: Open Payments
NPI 1730123746 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$163 in 5 payments from 4 companies in 2025. Trend: 2023 $127 · 2024 $16 · 2025 $163
Food & beverage: $163
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $81 |
| Indivior Inc. | 2 | $36 |
| ABBVIE INC. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: REXULTI, SUBLOCADE, VRAYLAR, CAPLYTA.
Industry payments across AZ — which companies pay providers there.
